GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Scaled Net Operating Assets

Allegra Medical Technologies (ASX:AMT) Scaled Net Operating Assets : -0.11 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Allegra Medical Technologies's operating assets for the quarter that ended in Dec. 2023 was A$0.29 Mil. Allegra Medical Technologies's operating liabilities for the quarter that ended in Dec. 2023 was A$0.60 Mil. Allegra Medical Technologies's Total Assets for the quarter that ended in Jun. 2023 was A$2.91 Mil. Therefore, Allegra Medical Technologies's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -0.11.


Allegra Medical Technologies Scaled Net Operating Assets Historical Data

The historical data trend for Allegra Medical Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Scaled Net Operating Assets Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.58 0.67 0.67 0.29

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.77 0.64 0.31 -0.11

Competitive Comparison of Allegra Medical Technologies's Scaled Net Operating Assets

For the Medical Devices subindustry, Allegra Medical Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's Scaled Net Operating Assets falls into.



Allegra Medical Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Allegra Medical Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2023 )
=(Operating Assets (A: Jun. 2023 )-Operating Liabilities (A: Jun. 2023 ))/Total Assets (A: Jun. 2022 )
=(2.912-1.284)/5.609
=0.29

where

Operating Assets(A: Jun. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.913 - 0.001
=2.912

Operating Liabilities(A: Jun. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.412 - 2.678 - 0.45
=1.284

Allegra Medical Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2023 )
=(Operating Assets (Q: Dec. 2023 )-Operating Liabilities (Q: Dec. 2023 ))/Total Assets (Q: Jun. 2023 )
=(0.287-0.599)/2.913
=-0.11

where

Operating Assets(Q: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.441 - 0.154
=0.287

Operating Liabilities(Q: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.053 - 0 - 1.454
=0.599

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.